Results
1374
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1374 companies
Cabaletta Bio
Market Cap: US$211.3m
A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.
CABA
US$2.36
7D
7.8%
1Y
-44.6%
Tonix Pharmaceuticals Holding
Market Cap: US$210.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.
TNXP
US$24.21
7D
-6.9%
1Y
65.8%
Atlantic International
Market Cap: US$210.2m
Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.
ATLN
US$3.50
7D
-23.9%
1Y
-41.2%
BioVersys
Market Cap: CHF 166.6m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 28.50
7D
-13.6%
1Y
n/a
Egetis Therapeutics
Market Cap: SEK 1.9b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.40
7D
-5.9%
1Y
22.2%
Ironwood Pharmaceuticals
Market Cap: US$206.3m
A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.
IRWD
US$1.39
7D
-1.4%
1Y
-65.4%
TaiGen Biopharmaceuticals Holdings
Market Cap: NT$6.2b
A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.
4157
NT$8.69
7D
4.1%
1Y
-40.3%
GC Cell
Market Cap: ₩288.5b
Develops cell therapy products.
A144510
₩19,200.00
7D
-6.6%
1Y
-40.2%
Helixmith
Market Cap: ₩286.0b
Develops biologic and natural nutraceutical products.
A084990
₩6,210.00
7D
0.6%
1Y
78.7%
BioInvent International
Market Cap: SEK 1.9b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 28.70
7D
-6.4%
1Y
-40.1%
S.Biomedics
Market Cap: ₩282.9b
S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products.
A304360
₩23,850.00
7D
-4.2%
1Y
-29.5%
Dimerix
Market Cap: AU$306.1m
A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
DXB
AU$0.51
7D
-1.0%
1Y
32.5%
Entrada Therapeutics
Market Cap: US$198.4m
A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.
TRDA
US$5.80
7D
7.0%
1Y
-64.7%
AGP
Market Cap: PK₨55.8b
Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.
AGP
PK₨199.45
7D
3.3%
1Y
79.8%
Botanix Pharmaceuticals
Market Cap: AU$304.0m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.15
7D
19.2%
1Y
-59.2%
Milestone Pharmaceuticals
Market Cap: US$195.8m
A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
MIST
US$2.00
7D
4.2%
1Y
30.7%
BioAge Labs
Market Cap: US$194.3m
A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.
BIOA
US$5.42
7D
10.6%
1Y
-74.2%
Sirnaomics
Market Cap: HK$1.5b
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$14.46
7D
-11.7%
1Y
322.8%
Sangamo Therapeutics
Market Cap: US$191.0m
A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.
SGMO
US$0.66
7D
21.6%
1Y
-23.4%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.8b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$30.60
7D
0%
1Y
-2.2%
Binh Dinh Pharmaceutical and Medical Equipment
Market Cap: ₫5.0t
Manufactures and trades in pharmaceuticals and medical equipment in Vietnam.
DBD
₫53,600.00
7D
-0.9%
1Y
19.5%
Selvita
Market Cap: zł693.8m
Operates as a contract research organization worldwide.
SLV
zł37.80
7D
0.5%
1Y
-33.5%
Biofarm
Market Cap: RON 810.0m
Manufactures and sells medicines in Romania.
BIO
RON 0.82
7D
-1.0%
1Y
5.7%
Orient Pharma
Market Cap: NT$5.7b
Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.
4166
NT$25.50
7D
-1.7%
1Y
-1.0%
HLB TherapeuticsLtd
Market Cap: ₩262.8b
A biotech company, develops pharmaceutical products in South Korea and internationally.
A115450
₩3,130.00
7D
-6.4%
1Y
-65.8%
Journey Medical
Market Cap: US$185.7m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.06
7D
-3.3%
1Y
23.4%
Hester Biosciences
Market Cap: ₹16.5b
Manufactures and trades in veterinary vaccines and animal health products in India and internationally.
524669
₹1,934.50
7D
-3.6%
1Y
-22.2%
Savior Lifetec
Market Cap: NT$5.6b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$17.75
7D
-1.4%
1Y
-17.4%
Diaceutics
Market Cap: UK£137.5m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.63
7D
8.3%
1Y
21.7%
TTK Healthcare
Market Cap: ₹16.3b
Engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India.
507747
₹1,154.55
7D
-2.6%
1Y
-31.3%
Genfit
Market Cap: €155.9m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€3.13
7D
-13.4%
1Y
-39.5%
Saniona
Market Cap: SEK 1.7b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 12.28
7D
2.2%
1Y
178.5%
Black Diamond Therapeutics
Market Cap: US$177.1m
A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
BDTX
US$3.40
7D
3.7%
1Y
-19.6%
Syncom Formulations (India)
Market Cap: ₹15.7b
Manufactures, markets, and sells pharmaceutical formulation products in India and internationally.
524470
₹16.71
7D
-6.6%
1Y
-24.0%
Lee's Pharmaceutical Holdings
Market Cap: HK$1.4b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$2.30
7D
-7.3%
1Y
93.3%
3billion
Market Cap: ₩245.5b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩7,740.00
7D
4.6%
1Y
n/a